Drug Information

Drug General Information
Drug ID
D0Y0BB
Former ID
DNC014148
Drug Name
3-(4-Chlorophenyl)-2-nortropene
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530502]
Formula
C13H14ClN
Canonical SMILES
C1CC2C=C(CC1N2)C3=CC=C(C=C3)Cl
InChI
1S/C13H14ClN/c14-11-3-1-9(2-4-11)10-7-12-5-6-13(8-10)15-12/h1-4,7,12-13,15H,5-6,8H2
InChIKey
QBSBBGLHCMPGNO-UHFFFAOYSA-N
PubChem Compound ID
9859279
Target and Pathway
Target(s) Sodium-dependent serotonin transporter Target Info Inhibitor [530502]
Sodium-dependent dopamine transporter Target Info Inhibitor [530502]
KEGG Pathway Serotonergic synapsehsa04728:Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Amphetamine addiction
Alcoholism
NetPath Pathway TCR Signaling Pathway
PANTHER Pathway 5HT1 type receptor mediated signaling pathway
5HT2 type receptor mediated signaling pathway
5HT3 type receptor mediated signaling pathway
5HT4 type receptor mediated signaling pathwayP00001:Adrenaline and noradrenaline biosynthesis
Parkinson disease
Dopamine receptor mediated signaling pathway
Pathway Interaction Database Alpha-synuclein signaling
Reactome Na+/Cl- dependent neurotransmitter transporters
WikiPathways Monoamine Transport
SIDS Susceptibility Pathways
NRF2 pathway
Synaptic Vesicle Pathway
Serotonin Transporter ActivityWP727:Monoamine Transport
Dopaminergic Neurogenesis
Parkinsons Disease Pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
Neurotransmitter Clearance In The Synaptic Cleft
References
Ref 530502Bioorg Med Chem Lett. 2009 Dec 15;19(24):6865-8. Epub 2009 Oct 23.Synthesis and monoamine transporter affinity of 3alpha-arylmethoxy-3beta-arylnortropanes.
Ref 530502Bioorg Med Chem Lett. 2009 Dec 15;19(24):6865-8. Epub 2009 Oct 23.Synthesis and monoamine transporter affinity of 3alpha-arylmethoxy-3beta-arylnortropanes.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.